BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 22129969)

  • 1. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
    Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated transcriptional co-activator p102 mediates angiotensin II type 1 receptor up-regulation and extracellular matrix overproduction in the high glucose-treated rat glomerular mesangial cells and isolated glomeruli.
    Wang Z; Ni J; Shao D; Liu J; Shen Y; Zhou L; Huang Y; Yu C; Wang J; Xue H; Lu L
    Eur J Pharmacol; 2013 Feb; 702(1-3):208-17. PubMed ID: 23376562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
    Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ
    Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM; del Re E; Brown D; Lin HY
    Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
    Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
    Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
    Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
    Li X; Cui X; Sun X; Li X; Zhu Q; Li W
    Phytother Res; 2010 Jun; 24(6):893-9. PubMed ID: 19960420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti-oxidant alpha-lipoic acid.
    Singh LP; Cheng DW; Kowluru R; Levi E; Jiang Y
    Cell Biochem Funct; 2007; 25(5):537-50. PubMed ID: 16892452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
    Pessôa BS; Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):56-66. PubMed ID: 21987533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
    Li JJ; Lee SH; Kim DK; Jin R; Jung DS; Kwak SJ; Kim SH; Han SH; Lee JE; Moon SJ; Ryu DR; Yoo TH; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F200-9. PubMed ID: 19369290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.
    Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC
    J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
    Kim SI; Han DC; Lee HB
    J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.